On a basic human level, a guidance upgrade signals “things are better than we thought they were”, so upgrades are worth noticing.

We like to take note when a small cap company upgrades profit guidance and today Vysarn (ASX: VYS) lifted profit guidance by more than 20%.

ASX small cap stock Probiotec (ASX: PBP) looks like it offers growth at a reasonable price.

The Mader Group share price has had a strong run lately, but does the valuation make sense?

Propel Funeral Partners (ASX: PFP) could be considered a lower risk ASX stock, because increasing demand can be confidently forecast.

DUG Technology (ASX: DUG) and Fineos (ASX: FCL) have certainly submitted improved numbers this quarterly reporting season.

NHS strikes are taking a toll on Alcidion’s sales cycle.

Korvest (ASX: KOV) is a low P/E stock with strong recent results, but does competition make business too difficult?

Close The Loop (ASX: CLG) is clearly good to the environment, but will the ASX stock be good to shareholders?

Both these stocks have disappointed over the long term, but are showing stronger results recently.

Austco Healthcare (ASX: AHC) has cash on the balance sheet, growing profits, and potential for further growth.

Lindsay Australia (ASX: LAU) and CTI Logistics (ASX: CLX) both showed strong profit growth in H1 FY 2023, but are the stocks cheap?

A first half profit, promises of growth, cash in the bank and a tiny market capitalisation

Both these businesses have significant insider ownership, and a history of long term earnings per share growth.

When the little fish tries to eat the big fish… in hopes of becoming the biggest fish!

Claude, Matt and Andrew interview Pro Medicus CEO Sam Hupert.

These three stocks all experienced strong growth in earnings in H1 FY 2023, and trade on modest multiples, if those earnings are sustained.

Trajan Group (ASX: TRJ) is a profitable founder-led company growing both organically and via acquisition.

The H1 FY 2023 PWR Holdings revenue growth was strong, but the company is reinvesting in growth.

The H1 FY 2023 Ebos Group results were strong, thanks to a combination of acquired and organic growth.